Akero Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Akero Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q3 2024.
  • Akero Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $820K, a 23.2% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $820K -$248K -23.2% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $884K -$243K -21.6% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $946K -$239K -20.2% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $1.01M -$234K -18.8% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 $1.07M -$229K -17.7% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $1.13M -$225K -16.6% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $1.19M -$221K -15.7% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $1.24M -$217K -14.9% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $1.3M -$214K -14.2% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $1.35M -$210K -13.4% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $1.41M -$206K -12.8% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $1.46M -$203K -12.2% Dec 31, 2021 10-K 2023-03-17
Q3 2021 $1.51M -$199K -11.6% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $1.56M Jun 30, 2021 10-Q 2021-08-13
Q1 2021 $1.61M +$1.39M +613% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $1.66M +$1.38M +494% Dec 31, 2020 10-K 2022-02-25
Q3 2020 $1.71M Sep 30, 2020 10-Q 2020-11-12
Q1 2020 $226K Mar 31, 2020 10-Q 2020-05-13
Q4 2019 $280K Jan 1, 2020 10-K 2021-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.